![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEW PCI HOT TOPICS
Minerva Cardioangiologica 2020 October;68(5):386-92
DOI: 10.23736/S0026-4725.20.05312-8
Copyright © 2020 EDIZIONI MINERVA MEDICA
language: English
Myocardial revascularization in chronic coronary syndromes: does viability matter?
Alessandra SCATTEIA 1, Anna BARITUSSIO 2, Chiara BUCCIARELLI-DUCCI 3 ✉
1 Division of Cardiology, Villa dei Fiori Hospital, Acerra, Naples, Italy; 2 Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy; 3 Bristol Heart Institute, NIHR Bristol Biomedical Research Centre, University of Bristol, Bristol, UK
Coronary artery disease (CAD) is the leading cause of death worldwide and improving the prognosis and survival of patients with ischemic heart disease remains a priority of cardiovascular specialists. This article will review the principles of myocardial viability, present the noninvasive imaging tests available to clinicians, as well as critically appraise the latest literature on myocardial viability, coronary revascularization and outcome with a final outlook at studies in the pipelines and future evidence in myocardial viability that will be soon available.
KEY WORDS: Acute coronary syndrome; Coronary artery disease; Myocardium